Dosing

IBRANCE® has a one tablet once a day regimen, regardless of dose strength1

ibrance_dosing

Adapted from IBRANCE® Summary of Product Characteristics.1

Only 7 tablets per week, 21 tablets in total per month1
IBRANCE® recommended dose modification for AEs1
Dosing

Adapted from IBRANCE® Summary of Product Characteristics.1

*If further dose reduction below 75 mg/day is required, discontinue the treatment.

 

  • Dose reductions or dose modifications due to any AE occurred in 38.4% of patients receiving IBRANCE® in randomised clinical studies regardless of the combination1

 

AE = adverse event; AI = aromatase inhibitor; IM = intramuscular; PO = orally.

Reference
  1. IBRANCE® Summary of Product Characteristics.

 

 

 

©2020 Pfizer. All rights reserved. PP-IBR-IRL-0501 Date of Preparation: March 2022 Legal Category: S1A